| Literature DB >> 30698411 |
Lingxian Meng1, Wenjuan Ma1, Shiyu Lin1, Sirong Shi1, Yanjing Li1, Yunfeng Lin1.
Abstract
DNAzymes are synthetic oligonucleotides that are capable of cleavaging target mRNA to exert gene-silencing activity and are considered as promising therapeutic agents. Dz13 is a DNAzyme that cleaves the mRNA of c-Jun and suppresses the growth of squamous cell carcinomas. However, DNAzymes exhibit low cellular uptake efficacy and require a suitable drug delivery system. In this study, we directly added the Dz13 sequence to the 5'-end of single-stranded DNA to form modified tetrahedral DNA nanostructures (TDN-Dz13). The TDNs were used to deliver the single-stranded DNAzyme Dz13 into cells. Dz13 delivered by the TDNs showed high cellular uptake efficiency and still maintained intracellular gene-silencing activity to cleave the target c-Jun mRNA, which reduced cell proliferation. This study may help find a convenient approach for the delivery of DNAzymes to regulate target genes.Entities:
Keywords: DNA nanomaterial; DNAzymes; c-Jun; drug delivery; gene silence; proliferation
Mesh:
Substances:
Year: 2019 PMID: 30698411 DOI: 10.1021/acsami.8b22444
Source DB: PubMed Journal: ACS Appl Mater Interfaces ISSN: 1944-8244 Impact factor: 9.229